-
Active Stocks to Watch: Xerox Corporation (NYSE:XRX), International Business Machines Corporation (NYSE:IBM), XBIOTECH INC. (NASDAQ:XBIT), Exelon Corporation (NYSE:EXC), GrafTech International (NYSE:GTI)
Xerox Corporation (NYSE:XRX) in last trading activity increased 0.97% to close at $11.48. Company weekly performance is 2.14% while its quarterly performance stands at -15.68%. Xerox Corporation (NYSE:XRX) is -19.26% away from its 52 week high. Xerox (NYSE: XRX) announced its acquisition of Healthy Communities Institute (HCI), a Berkeley, Calif.-based company with a leading cloud…
-
Why Making Dramatic Moves: BioTime (NYSEMKT:BTX), Microsoft Corporation (NASDAQ:MSFT), FLIR Systems (NASDAQ:FLIR), XBIOTECH INC. (NASDAQ:XBIT), Westport Innovations Inc. (NASDAQ:WPRT)
On Monday shares of BioTime, Inc. (NYSEMKT:BTX) closed at $4.84. Company’s sales growth for last 5 years was 22.30%. On 13 May, BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) announced that Cell Cure has been awarded a grant for 2015 of 6.24 million shekels (approximately $1.61 million) from…
-
Why Making Dramatic Moves: COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL), XBIOTECH INC. (NASDAQ:XBIT), Caterpillar Inc. (NYSE:CAT), Transportadora (NYSE:TGS), Delta Air Lines (NYSE:DAL)
On Friday shares of COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) closed at $15.62. Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced on 14 May, the closing of its initial public offering of 6,670,000 shares of its common stock at a price to the public of $12.00 per share, before underwriting discounts and commissions, including shares issued upon the exercise of…
-
Investors Watch List: XBIOTECH INC. (NASDAQ:XBIT), Vale S.A. (NYSE:VALE), Enduro Royalty Trust (NYSE:NDRO), FXCM Inc. (NYSE:FXCM), Omega Protein Corporation (NYSE:OME)
On Thursday shares of XBIOTECH INC. (NASDAQ:XBIT) closed at $18.23. On April 29, XBIOTECH INC. (NASDAQ:XBIT), announced that it has enrolled the first patient into its revised U.S. Phase 3 study of Xilonix™ in metastatic colorectal cancer patients. Xilonix, XBiotech’s monoclonal True Human antibody therapy, is designed to block chronic inflammation associated with malignant tumor…
-
Top Wall Street Stories: XBIOTECH INC. (NASDAQ:XBIT), AK Steel Holding Corporation (NYSE:AKS), Goldcorp Inc. (NYSE:GG), RetailMeNot (NASDAQ:SALE), China Biologic Products (NASDAQ:CBPO)
On Tuesday shares of XBIOTECH INC. (NASDAQ:XBIT) closed at $18.20. XBiotech (NASDAQ:XBIT) announced 29 April, that it has enrolled the first patient into its revised U.S. Phase 3 study of Xilonix™ in metastatic colorectal cancer patients. Xilonix, XBiotech’s monoclonal True Human antibody therapy, is designed to block chronic inflammation associated with malignant tumor growth. AK…
-
Shining on Major News: GenVec (NASDAQ:GNVC), XBIOTECH INC. (NASDAQ:XBIT), Norfolk Southern Corporation (NYSE:NSC), GasLog Partners LP (NYSE:GLOP), Qunar Cayman Islands (NASDAQ:QUNR)
On Thursday shares of GenVec, Inc. (NASDAQ:GNVC) closed at $2.52. Company’s sales growth for last 5 years was -15.50% and EPS growth for next 5 years is recorded as 35.00%. On April 22, GenVec, Inc. (NASDAQ:GNVC) announced that the Board of Directors of GenVec, Inc. appointed Michael Richman as a director of the company. XBIOTECH…
-
Trending Stocks: XBIOTECH INC. (NASDAQ:XBIT), Hewlett-Packard Company (NYSE:HPQ), Rand Logistics (NASDAQ:RLOG), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), HudBay Minerals (NYSE:HBM)
On Wednesday shares of XBIOTECH INC. (NASDAQ:XBIT) closed at $19.94. XBiotech Inc. (Nasdaq:XBIT) announced on 17 April, the closing of its initial public offering of 4,000,000 shares of its common stock at an initial public offering price of $19.00 per share for a total offering amount of $76,000,000, before the underwriting discounts and commissions and…
-
Stock Runners: Facebook (NASDAQ:FB), XBiotech Inc (NASDAQ:XBIT), Galena Biopharma (NASDAQ:GALE), McCormick & Company, Incorporated (NYSE:MKC), Omnicom Group Inc. (NYSE:OMC)
On Thursday shares of Facebook, Inc. (NASDAQ:FB) closed at $82.31. Company’s sales growth for last 5 years was 74.20% and EPS growth for next 5 years is recorded as 31.02%. Facebook, Inc. (NASDAQ:FB) said that, it is to appeal a ruling that it must pay £20,000 in damages to a convicted child abuser who featured…